GlaxoSmithKline (GSK) new online system will enable researchers to request access to anonymised patient level data that sit behind the results of clinical trials.
It is hoped that sharing these data with researchers will help to further scientific research, increase understanding of new and current medicines and ultimately improve patient care.
Will other pharmaceutical companies follow?
Find out more:
- GSK gives update on plans to share detailed clinical trial data as part of its commitment to transparency
- Visit #AllTrials website and donation site
- All our posts: All Trials – Ben Goldacre – Big Pharma
I just added your blog to my rss reader, great stuff.
thank you !